CREB is a pivotal mediator of activity-regulated gene transcription that underlies memory formation and allocation. The contribution of a key CREB cofactor, CREB-regulated transcription coactivator 1 (CRTC1), has, however, remained elusive. Here we show that several constitutive kinase pathways and an activity-regulated phosphatase, calcineurin, converge to determine the nucleocytoplasmic shuttling of CRTC1. This, in turn, triggered an activity-dependent association of CRTC1 with CREB-dependent regulatory elements found on IEG promoters. Forced expression of nuclear CRTC1 in hippocampal neurons activated CREB-dependent transcription, and was sufficient to enhance contextual fear memory. Surprisingly, during contextual fear conditioning, we found evidence of nuclear recruitment of endogenous CRTC1 only in the basolateral amygdala, and not in the hippocampus. Consistently, CRTC1 knockdown in the amygdala, but not in the hippocampus, significantly attenuated fear memory. Thus, CRTC1 has a wide impact on CREB-dependent memory processes, but fine-tunes CREB output in a region-specific manner.
INTRODUCTION

Ca
2+
/cAMP-responsive element-binding protein (CREB) is a ubiquitous transcription factor and is activated by phosphorylation in response to external stimuli (Mayr and Montminy, 2001 ). In the nervous system, CREB-dependent gene expression is essential for long-term memory and plasticity (Bito and Takemoto-Kimura, 2003; Bourtchuladze et al., 1994; Greer and Greenberg, 2008; Josselyn et al., 2001; Kida et al., 2002; Okuno et al., 2012; Silva et al., 1998; Suzuki et al., 2011) . The expression of various neuronal immediate early genes (IEGs)-genes that are primarily induced by neuronal activity-such as c-Fos, brain-derived neurotrophic factor (BDNF), and activity-regulated cytoskeleton-associated protein (Arc, also known as Arg3.1) is predominantly CREB dependent (Bito et al., 1997; Okuno, 2011) . Local manipulation of CREB activation has further revealed strong evidence supporting a critical role of CREB in the formation of memory engrams and allocation of memory within an active set of neurons (Cowansage et al., 2013; Han et al., 2007; Zhou et al., 2009) . In spite of this significance, our current understanding about the mechanisms by which the promoters and enhancers of such IEGs are robustly stimulated by neuronal activity through convergent effects of different sets of transcription factors and associated coactivators remains limited. Furthermore, we lack insights on how differential coordination of transcription may regulate engrams in distinct brain areas and cooperatively produce a long-term modification of cognitive performance (Lonze and Ginty, 2002; Nonaka, 2009; Nonaka et al., 2014) .
It has been suggested that IEG expression profiles during basal and activated states may differ among brain regions, and such data were considered as functional evidence in support for an uneven contribution of distinct brain regions during cognitive behavior (Frankland et al., 2004; Okuno, 2011; Tse et al., 2011) . In keeping with this, recent work has indicated differential CREB phosphorylation profiles and time courses in different brain regions during reconsolidation and extinction of fear memory (Cowansage et al., 2013; Mamiya et al., 2009) . However, it remains unsolved whether the distinctive neuronal activities in those brain areas are the sole determinants of such differential activity-regulated transcription. An alternative hypothesis that has not been tested so far is the possibility that cellular consolidation of memory-related events might employ distinct CREB complexes in different brain areas to convert incoming synaptic inputs to long-term events.
CREB-regulated transcriptional coactivator (CRTC), also known as transducer of regulated CREB activity (TORC), has recently emerged as a unique CREB coactivator that binds to the basic leucine zipper (bZIP) region of CREB (Conkright et al., 2003) . CRTCs are Ser/Thr-rich proteins (Ser/Thr composition = 18.3%-21.1%) with multiple phosphorylation and glycosylation sites. Among the known isoforms of CRTC (CRTC1, 2, and 3), CRTC2 has been best explored. In CRTC2, the covalent modification of Ser 171 , by alternative phosphorylation/glycosylation, determines its subcellular localization: nuclear in the glycosylated or virgin state, and cytoplasmic in the phosphorylated states. CRTC2 plays key roles in gluconeogenesis, insulin signaling, and cell proliferation in the liver and pancreas (Altarejos and Montminy, 2011), whereas CRTC3 contributes to the development of obesity by attenuating b-adrenergic receptor signaling in adipose tissue (Song et al., 2010) . CRTC1-null mice also develop obesity as a result of dysregulation of the hypothalamic feeding center (Altarejos et al., 2008) . Consistently, in Caenorhabditis elegans, where only one copy of CRTC gene exists, CRTC1-dependent transcription via CREB is critical for the control of energy homeostasis and longevity (Mair et al., 2011) . Interestingly, CRTC1, an isoform that is most abundantly expressed in the central nervous system (Watts et al., 2011) , translocates to the nucleus upon receipt of dendritic synaptic inputs (Ch'ng et al., 2012) . CRTC1 has been implicated in regulation of the dendrite arborization of developing cortical neurons (Finsterwald et al., 2010; Li et al., 2009) , in the control of neuronal survival after ischemia (Sasaki et al., 2011) , and regulation of circadian clock (Jagannath et al., 2013; Sakamoto et al., 2013) . Despite the critical importance of nuclear CREB-regulated transcription in cognition, the mechanisms underlying the nucleocytoplasmic shuttling of CRTC1, and CRTC1's impact on memory-related processes, have remained elusive.
In order to address these questions, we here identified key amino acid residues underlying nuclear shuttling of neuronal CRTC1 via pharmacological and mass spectrometric analyses. Quantitative understanding of CRTC1's phosphorylation states enabled rational designing of a constitutively active mutant form of CRTC1 (caCRTC1) whose localization was restricted to the nucleus of neurons both in vitro and in vivo. Chromatin immunoprecipitation (ChIP) assays revealed an activity-dependent association of CRTC1 with CREB-regulated elements on active IEG promoters. Taking advantage of caCRTC1, we then found that the nuclear accumulation of CRTC1 was sufficient to markedly stimulate neuronal CREB-dependent gene expression even in the absence of evoked synaptic activity in vitro or in naive mice in vivo. Mice virally expressing caCRTC1 in the dorsal hippocampus showed enhancement of long-term contextual fear memory, which was accompanied by enlargement of dendritic spines. Surprisingly, during contextual fear conditioning (CFC), nuclear recruitment of endogenous CRTC1 was detected in the basolateral amygdala (BLA), but not in the hippocampus. In keeping with this, CRTC1 knockdown in the amygdala, but not in the hippocampus, significantly attenuated fear memory. Taken together, our study provides evidence for a wide impact of CRTC1 on nuclear CREB-mediated memory processes, and also indicates that the phosphorylation states critical for activity-dependent nuclear translocation of CRTC1 are controlled in a region-specific manner that is distinct from the regulation of CREB phosphorylation. Thus, CRTC1 may act as a localized, rather than global, tunable switching mechanism for specifying CREB output and activity-dependent transcription, contributing to optimizing the formation and allocation of memory across brain regions. CRTC1 is a Ser/Thr-rich protein (Ser/Thr content = 21.1%).
RESULTS
Nuclear
To enable high coverage identification for critical phosphorylated residues, we performed mass spectrometric analysis of CRTC1 immunoprecipitated from cultured cortical neurons, and identified 11 Ser or Thr phosphorylation sites ( Figure 1A ). To investigate activity-dependent regulation of these candidate phosphorylation sites, we established a translocation assay in primary cultures of mouse hippocampal neurons. The neurons were initially silenced with 1 mM tetrodotoxin (TTX) in order to restrict CRTC1 in the cytoplasm and then synaptically activated by washing out TTX and adding a BIC/4AP cocktail (30 mM bicuculline, 100 mM 4-aminopyridine, 100 mM glycine, and 1 mM strychnine) to induce nuclear translocation of CRTC1 (Figure 1B) . The neurons were fixed after various incubation times, and CRTC1 immunoreactivity (IR) was measured in the cytoplasm and in the nucleus ( Figures 1C and 1D ). The activitydependent nuclear translocation of CRTC1 was rapid, achieving a peak and plateau within 2 min after stimulus onset ( Figure 1C ). Once the culture medium was returned to the TTX-containing solution, CRTC1 was exported from the nucleus within 30 min ( Figure 1D ). The distribution and redistribution of CRTC1 may thus serve as a dynamic trace that integrates the incoming synaptic activity of the immediate past. Diverse kinase and phosphatase pathways have previously been implicated in regulation of the nucleocytoplasmic shuttling of CRTC1-3 (Koo et al., 2005; Screaton et al., 2004) . We therefore examined the kinases that controlled the phosphorylation states of neuronal CRTC1. Phenformin, a potent activator of many kinases including AMP-activated protein kinase (AMPK), prevented the occurrence of both the activity-dependent nuclear translocation of CRTC1 (Figure S1A available online) and BIC/ 4AP-induced CRE-dependent transcription activity ( Figure 1E ). Conversely, compound C, an inhibitor of AMPK and salt-inducible kinase 2 (SIK2), promoted the nuclear translocation of CRTC1 in the presence of spontaneous activity ( Figure S1B ), as well as increased the extent of synaptically induced CREdependent promoter activity ( Figure 1F ). Consistent with these results, additional experiments showed that kinases that have been suggested to function upstream of SIK2, including protein kinase A (PKA) ( Figure S1C ) as well as a Ca 2+ /calmodulin-dependent kinase kinase (CaMKK)-CaMKI/IV cascade ( Figure S1D ), contributed to the regulation of the nuclear translocation of CRTC1. Furthermore, overexpression of constitutively active or dominant-negative forms of microtubule affinity-regulating kinase 2 (MARK2) shifted CRTC1 localization to the cytoplasm or nucleus, respectively ( Figure 1G ), implicating MARK2 as an independent upstream regulator of neuronal CRTC1. In contrast, we found that a cocktail consisting of inhibitors of a Ca 2+ / calmodulin-dependent protein phosphatase calcineurin (CsA/ FK, cyclosporin A and FK506) attenuated the activity-dependent nuclear translocation of CRTC1 in a concentration-dependent manner ( Figure 1H ), while also inhibiting activity-induced CREdependent promoter activity ( Figure 1F ).
Together, these findings indicated that in synaptically connected hippocampal neurons, the basal constitutive phosphorylation states of CRTC1 were largely under the control of SIK2/AMPK and MARK2. In combination, these constitutive kinases gated the onset of CRTC1 nuclear translocation, which was then turned on by an activity-dependent calcineurin-mediated dephosphorylation to facilitate CRE-dependent gene expression.
We next turned to cultured cortical neurons to determine the key phosphorylation sites underlying CRTC1's nuclear shuttling. We found marked changes in the electrophoretic mobility of CRTC1 associated with its phosphorylation or dephosphorylation. The abundance of the lowest-mobility (upper) bands were increased on exposure of neurons to phenformin or to CsA/FK, whereas synaptic stimulation of neurons or in vitro treatment of cell lysates with calf intestinal phosphatase (CIP) increased the intensity of the highest-mobility (lower) band (Figure 2A ). Alanine-scanning mutagenesis based on the mass spectrometry data ( Figure 1A ) revealed that S151A and S245A were mutations that attenuated the phosphorylation-related mobility shift of FLAG epitope-tagged CRTC1 ( Figures 2B, S2A , and S2B). Consistent with this, increased synaptic activity triggered dephosphorylation of these Ser residues in neurons ( Figures  S2C and S2D) . Interestingly, the combined double mutant (S151A/S245A) lost any activity-dependent mobility shift (''ca'' in Figure 2C Figure 3A) , although mutation of either site alone was not sufficient to induce such a degree of nuclear translocation ( Figure S3A ; data not shown). A sizable portion of the CRTC1 mutant (S151A/S245A) remained in the nucleus when stimulated in the presence of CsA/FK, indicating that dual-alanine mutation of Ser 151 and Ser 245 conferred resistance to calcineurin inhibitors ( Figure 3B ). A constitutively cytosolic mutant (mutCN) was generated by introducing mutations in two consensus calcineurin-binding motifs (PxIxIT) of CRTC1 (Screaton et al., 2004 ) ( Figure 3A ). The activities of both of these mutant proteins in neurons were quantified by CRE-reporter assays ( Figure 3C ). First, knockdown of CRTC1 with two independent short-hairpin RNAs (shRNAs) (shCRTC1-#1 and shCRTC1-#2) showed that CRTC1 is critical for activity-regulated CRE-dependent transcription ( Figure 3C ). Expression of an shRNA-resistant form of wild-type CRTC1 (WT-CRTC1res) restored the transcription activity in a concentration-dependent manner ( Figures S3C-S3E ). However, expression of S151A/S245A (caCRTC1res) in this context conferred a high level of CRE-dependent transcription even in CRTC1-depleted neurons exposed to TTX, and this effect was increased further in the presence of BIC/4AP ( Figure 3C ). The latter effect of BIC/4AP was blocked by CsA/FK, implying an additional calcineurin-sensitive mechanism to further facilitate CRE-dependent transcription. In contrast, CRTC1 (mutCNres) did not evoke transcriptional activity in CRTC1-depleted neurons exposed to either TTX or BIC/4AP ( Figure 3C ). Together, in contrast to previous studies emphasizing the role of Ser 151 , our results revealed a critical role for both Ser 151 and Ser 245 . 
Neuron
Region-Specific Activation of CRTC1-CREB in Memory
Given the ability of S151A/S245A mutant of CRTC1 to confer CRE-dependent promoter activity in neurons even in the presence of TTX, we hereafter refer to this mutant as caCRTC1.
Expression of caCRTC1 did not increase the phosphorylation of CREB at Ser 133 in neurons exposed to either TTX or BIC/4AP
(data not shown), suggesting that the nuclear accumulation of CRTC1 in the absence of CREB phosphorylation is sufficient to induce CRE-dependent transcription. To examine this notion further in an acute system, we constructed caCRTC1-ER T2 by fusing caCRTC1 to a mutant form of the estrogen receptor (ER) that is receptive exclusively to a synthetic ligand of ER (Figure 3D ). caCRTC1-ER T2 successfully translocated from cytoplasm to nucleus by 4-hydroxytamoxifen (4-OHT) ( Figure 3E ). Exposure of the transfected cells to 4-OHT in TTX-containing medium for 4 hr resulted in a marked increase in CRE-dependent transcription in neurons ( Figure 3F ). This activity was further increased when BIC/4AP was applied with 4-OHT ( Figure S3F ), suggesting that there is a combinatorial regulation of nuclear CRTC1 and other CRTC1-independent CREB regulatory components downstream of synaptic activity (see also Figure 3C ). Notably, the 4-OHT-induced acute caCRTC1-ER T2 nuclear accumulation was not accompanied by detectable increase in the level of phosphorylated CREB ( Figure 3G ). We further found that c-Fos is induced in this condition in the absence of synaptic activity ( Figure S3G ). Together, these results supported the notion that the nuclear translocation of CRTC1 was sufficient to induce CRE-dependent transcription in neurons, and also that nuclear CRTC1 might synergize with other synaptic activity-driven CREB signaling cascades to facilitate CRE-dependent transcription.
CRTC1 Complexes to the IEG Promoter Regions in an Activity-Dependent Manner and Mediates ActivityDependent IEG Transcription in Neurons
To determine the role of nuclear CRTC1 in neuronal CREBdependent gene expression, we next tested whether CRTC1 directly bound IEG promoters. We prepared cortical neurons in which Myc-tagged CRTC1 was expressed to a minimal level, such that no additional increase in transcription activity was detectable in sensitive reporter assays ( Figure S4A ). Quantitative ChIP assays using an anti-Myc antibody revealed that CRTC1 was complexed in an activity-dependent manner with the promoters of Arc, c-fos, and BDNF, and rather constitutively with the zif-268 promoter ( Figure 4A ). ChIP assays using anti-CRTC1 antibodies further confirmed the binding of endogenous CRTC1 to CRE sites of IEG promoters in high K + -treated cortical neurons ( Figure S4B ). To examine if CRTC1 associates with the promoters via CREB, we coexpressed A-CREB, a specific inhibitor of CREB function that binds to bZIP domain of CREB with high affinity (Ahn et al., 1998) . Expression of A-CREB completely blocked CRTC1-dependent transcription activity ( Figure 4B ; see also Figure S4G) . Together, we conclude that a functional CRTC1-CREB complex was recruited to the CRE sites in IEG promoters in an activity-regulated manner.
To examine the target specificity of CRTC1 on CRE sites among many regulatory elements in the promoter, we took advantage of the Arc promoter, which contains a single half-CRE site in the distal enhancer element termed SARE (Kawashima et al., 2009 ) that is positioned about 7 kb upstream of the transcription start site of Arc gene ( Figure 4C ). Knockdown of CRTC1 significantly attenuated the synaptic activity-dependent component of the full-length Arc promoter activity, and this effect was reversed at least in part by expression of WT-CRTC1res (Figure 4D) . Furthermore, expression of caCRTC1 increased the transcriptional activity of the promoter in the presence of TTX to a level similar to that observed in control neurons stimulated with BIC/4AP ( Figure 4E ). The combination of caCRTC1 expression and BIC/4AP treatment induced an additive effect, whereas mutation of the half-CRE site in the Arc promoter abolished the effects of caCRTC1 both in TTX and in BIC/4AP ( Figure 4E ). Next, to test if there is any local interaction, we used the SARE-minCMV promoter ( Figure 4F ). This promoter was largely dependent on CRTC1 (data not shown), similar to the results obtained with the full-length Arc promoter ( Figure 4D ). Expression of caCRTC1 induced a marked increase in the SARE-minCMV promoter activity, and this effect was abolished by mutation of the CRE motif (mCRE), but was not influenced by mutation of the MRE, MEF2 response element (mMRE), or SRE, the serum response element (mSRE) ( Figure 4F ). These results suggested that CRTC1 acts solely and directly at the half-CRE of SARE without interaction with MEF2, SRF, or other nonselective factors.
To determine whether these findings with the Arc promoter are applicable to other CREB-dependent IEGs, we performed reporter assays with the proximal promoter of the c-fos gene and . ChIP eluates were subjected to qPCR with primers for the SARE of the Arc promoter, c-fos promoter (proximal), BDNF promoter (pIV), zif268 promoter, or for the unrelated region 7 kb upstream of SARE (Nega) (left). The ratio of the recovery obtained with anti-Myc to that obtained with control IgG is shown as fold enrichment (right). Control ChIP assays performed with untransfected neurons did not yield substantial recovery with anti-Myc antibody (data not shown). Data are from six independent experiments. *p < 0.05. (B) CRE-reporter assay of neurons transfected with WT-CRTC1 and A-CREB. Note that the transcription activity in this assay is dependent on CRTC1 as shown in Figure 3C , and this component was totally blocked by the expression of A-CREB. (C) Schematic representations of the mouse Arc promoter and corresponding wild-type (7 kb) and mutant (mCRE) promoter luciferase reporter constructs. The CRE is located at À7 kb in the SARE region (yellow box). (D) Luciferase reporter assay of the Arc promoter (7 kb). Rat cortical neurons transfected with the Arc promoter-reporter construct, an shRNA expression vector for control (shNega) or CRTC1 (shCRTC1-#2), and an expression vector for CRTC1res were exposed to TTX or to BIC/4AP for 4 hr. **p < 0.01, ***p < 0.001. (E) Luciferase reporter assay performed as in (D) transfected with an expression vector for caCRTC1 or control GFP. **p < 0.01, ***p < 0.001. (F) Luciferase reporter assay of cortical neurons transfected with SARE-minCMV promoter (top) or the corresponding plasmid with mutations in the CRE, MRE, or SRE (mCRE, mMRE, and mSRE, respectively) and an expression vector for caCRTC1 or control GFP (bottom). ***p < 0.001. See also Figure S4. promoter IV of the BDNF gene (pIV-BDNF), both of which are dependent on CREB for activity (Sassone-Corsi et al., 1988; Tabuchi et al., 2000; West et al., 2001) . While activity-independent phosphoglycerate kinase (PGK) promoter activity was not affected by CRTC1 ( Figure S4C ), BIC/4AP-induced activities for c-fos promoter or pIV-BDNF were attenuated by CRTC1 knockdown, and this effect was reversed in a concentrationdependent manner by expression of WT-CRTC1res ( Figures  S4D and S4E ; see also Table 1 and Figure S3D ). These c-fos and pIV-BDNF promoter activities were markedly increased by expression of caCRTC1 even in the TTX condition, but the caCRTC1 that lacks the N-terminal CREB-binding domain (ca-DCBD) had no effect ( Figure S4F ; data not shown). Furthermore, all of the caCRTC1 effects were completely blocked by coexpression of A-CREB ( Figure S4G) .
Coimmunoprecipitation experiments in transfected cells revealed that CRTC1 is capable of binding the S133A mutant of CREB ( Figure S4H ). In addition, caCRTC1 was coimmunoprecipitated with an antibody to CBP from lysates of cortical neurons silenced with TTX when CREB phosphorylation is minimized ( Figure S4I ). These results suggested that caCRTC1 might help recruit CBP to CRE sites when it is bound to the Ser 133 unphosphorylated form of CREB in neurons maintained in the TTX condition. In keeping with these findings, our mass spectrometric analysis identified RNA helicase A as an interaction partner of CRTC1 (data not shown), which was previously shown to mediate the association of CBP with the RNA polymerase II complex (Nakajima et al., 1997) . Together, these results suggested that following nuclear accumulation of caCRTC1 and its binding to CREB, CBP and likely other factors such as TAF II 130 or TAF4 might be recruited (Conkright et al., 2003; Jeong et al., 2012; Ravnskjaer et al., 2007) , thereby perhaps even bypassing the need for activity-dependent CREB phosphorylation for CREB/ CBP-mediated gene expression.
Dynamics of Nuclear Localization of CRTC1 Play a Critical Role in Controlling Long-Term Memory Formation
We next examined whether nuclear CRTC1 upregulates the expression of endogenous IEGs in neurons. Immunocytochemistry (ICC) of cultured neurons transfected with caCRTC1 revealed that caCRTC1 induced the expression of both Arc and c-Fos in the presence of TTX to an extent similar to that induced by synaptic activity ( Figures S5A and S5B ). To ascertain these findings in vivo, we constructed adeno-associated viruses (AAVs) encoding GFP plus caCRTC1 (AAV-caCRTC1) or GFP alone (AAV-GFP) and injected them into the CA regions of the mouse hippocampi ( Figure 5A ). One week after the injection, caCRTC1 expression was observed in CA1 pyramidal neurons ( Figure 5B ). Consistent with our results in cultured neurons, the expression of Arc, c-Fos, and BDNF increased in the infected CA portions of the hippocampus that were injected with AAVcaCRTC1, while no change was detected when injected with AAV-GFP ( Figures 5C-5E ). We found that IEG expression in vivo was also increased in some noninfected neurons, though much less consistently and to a lower extent ( Figures 5C-5E , right panels; Figures S5C-S5E ). This could reflect either increased excitability of caCRTC1-expressing neurons that spread through the hippocampal network, or possibly an effect of released BDNF toward neighboring neurons, as suggested by increased BDNF-IR around some, but not all, infected neurons (e.g., Figures 5E and S5E) . Collectively, we conclude that, under our experimental conditions, forced nuclear localization of CRTC1 in hippocampal CA neurons induces significant upregulation of neuronal IEG products such as Arc, c-fos, and BDNF throughout the infected brain areas in vivo. Next, we investigated the consequences of caCRTC1 expression in vivo. Previous observations in cultured hippocampal slices implicated CRTC1 activity in the regulation of dendritic morphology (Li et al., 2009 ). We used a two-vector lentivirus system to confer sparse expression of caCRTC1 in hippocampal CA1 neurons (Hioki et al., 2009 ) for morphological analyses. We found that caCRTC1 expression induced Arc and c-Fos expression as early as 1 week after infection. We then acquired stacks of images of dendritic spines present on thin secondary dendrites of CA1 pyramidal cells in the stratum radiatum and performed 3D reconstruction to compare various spine parameters. Expression of caCRTC1 had no detectable effect on spine density (Figures S5F and S5G ). In contrast, caCRTC1 expression induced a significant enlargement of spine heads ( Figures S5F and S5G) . The nuclear accumulation of CRTC1 in hippocampus thus appeared to induce a generalized spread of morphological plasticity of dendritic spines without altering spine density. The ability of caCRTC1 to upregulate the CRTC1 knockdown efficiency was tested in four different experimental systems shown in the figures (reference figures) and quantified. CRTC1 levels for shCRTC1-#1-and -#2-expressing systems are shown as percentages of those for shNega. In western blotting (WB), the background was defined in the area of 110-130 kDa (the size of mEGFP-CRTC1) within the lane of the mEGFP-CRTC1 nonexpressing sample. In ICC and IHC, the background was defined in the area where there are no cells or tissues, respectively, and subtracted. Please note the shCRTC1-#1 is more effective in suppressing CRTC1 than shCRTC1-#2 in vivo (both in the amygdala and hippocampus) and of equal potency as shCRTC1-#2 in neuronal cultures, while shCRTC1-#2 appears to be more effective than -#1 in HEK293 cells. expression of a subset of IEGs in vivo prompted us to test the impact of caCRTC1 expression on a hippocampus-dependent behavior, the CFC test. To maximize the infection efficiency, we switched to AAVs and bilaterally injected AAV-GFP or -caCRTC1 into mouse hippocampal CA regions. The AAVderived expression increased gradually during the initial 4 weeks after injection and reached a plateau thereafter. To minimize any cumulative aberration in hippocampal circuit dynamics induced by upregulation of IEGs, we performed the test in 1 week post injection. The long-term contextual fear memory was significantly enhanced in mice injected with AAV-caCRTC1 (Figure 5F ). After the test, the extent of caCRTC1 expression was quantified by immunohistochemistry (IHC) ( Figure 5B) . A chisquare test suggested that animals with a higher or lower expression of CRTC1 tended to show a higher or lower freezing score, respectively, in reference to the medians of the respective parameters (df = 1, p < 0.05) ( Figure 5G ).
CRTC1 Plays a Critical Region-Specific Role in the BLA during Fear Memory Formation
To test whether endogenous CRTC1 is involved in learning and memory, we first monitored CRTC1's localization in the BLA neurons during CFC. While CRTC1 remained largely cytoplasmic in animals in the home cage, pairing the context (conditioned stimulus [CS] ) with the electric foot shock (unconditioned stimulus [US]) triggered a nuclear accumulation of CRTC1 in some populations of BLA neurons ( Figure 6A ). In contrast, however, the CS-US pairing did not induce nuclear translocation of CRTC1 in the hippocampus ( Figure 6B ). A much stronger stimulus, such as an electroconvulsive shock (ECS), triggered nuclear accumulation of CRTC1 in a subset of hippocampal neurons ( Figure 6C ), suggesting that the gating mechanism to prevent nuclear translocation might be more preponderant in the hippocampus under physiological conditions.
To ascertain the relevance of this region-specific translocation, we set out to examine the requirements of CRTC1 in these areas. We bilaterally injected AAV vectors for two CRTC1 knockdown constructs and a control AAV-shNega into the BLA (Table 1). After 4 weeks, when CRTC1-IR was greatly weakened by knockdown ( Figures 7A, S6A , and S6B; Table 1), both cued and contextual fear conditioning test performances were significantly worsened in the AAV-shCRTC1-#1-injected mice (Figure 7B ), in keeping with its potency to suppress the task-related induction of both c-Fos and Arc ( Figures 7C, 7D, S6C , and S6D). The fear memory defects did not reach statistical significance in the AAV-shCRTC1-#2 group (Figure 7B) , as a subset of CRTC1-regulated genes such as Arc were not fully inhibited owing to the lower in vivo knockdown potency of shCRTC1-#2 ( Figure S6D ; Table 1 ). Forced expression of caCRTC1 in BLA did not enhance long-term fear memory formation ( Figure S6E ), suggesting that CRTC1 signaling is critical, but easily saturates in the amygdala in accordance with enriched expression of CRTC1 in the amygdala (Watts et al., 2011) .
In the hippocampus, shCRTC1 virus produced a significant reduction in CRTC1 as well (Figures 7E and S6F ; Table 1 ). However, CRTC1 knockdown had little effect on contextual fear memory under an experimental condition in which hippocampal caCRTC1 expression promoted long-term memory ( Figure 7F ). This lack of sensitivity to hippocampal CRTC1 knockdown was not altered by a change in foot shock strength ( Figure S6G ). A) IHC using an anti-CRTC1 antibody of the mouse injected in BLA with AAV-shNega, -shCRTC1-#1, and -shCRTC1-#2 at 4 weeks post injection. GFP is expressed from one of the cassettes of AAV-shRNA vectors. We observed no significant gross neuronal death in AAV-injected areas, as examined with Hoechst 33342 counterstaining (data not shown). Scale bar, 500 mm. White lines in the CRTC1-IR images are the lines used for quantification in Figure S6A. (B) Cued and contextual fear conditioning test of mice injected with AAV-shNega, -shCRTC1-#1, or -shCRTC1-#2 bilaterally in the BLA at 4 weeks post injection. One-way ANOVA with post hoc Tukey-Kramer test; cued test (tone), ANOVA p = 0.010, **p < 0.01 for shNega versus sh#1; contextual test, ANOVA p = 0.037, **p < 0.05 for shNega versus sh#1 (shNega n = 14, sh#1 n = 15, sh#2 n = 20); note that shCRTC1-#2 is less efficient in knockdown in vivo (Table 1) Figure S6D ). (E) IHC using an anti-CRTC1 antibody of the mouse hippocampus infected with AAV-shNega, -shCRTC1-#1, and -shCRTC1-#2 at 4 weeks post injection. Scale bar, 200 mm. (F) Contextual fear conditioning test (0.2 mA) of mice injected with AAV-shNega, -shCRTC1-#1, or -shCRTC1-#2 (shNega n = 11, sh#1 n = 7, sh#2 n = 9) bilaterally in the hippocampus at 4 weeks post injection. n.s., not significant by one-way ANOVA. (G) IHC using an anti-c-Fos antibody of the dentate gyrus area of the hippocampus infected with AAV-shNega, -shCRTC1-#1, and -shCRTC1-#2 at 4 weeks post injection with or without enriched environment. Scale bar, 100 mm. Behavioral and histological analyses were carried out by an experimenter blinded to the virus type. See also Figure S6 . Furthermore, CRTC1 knockdown had no effect on enriched environment-induced expression of c-Fos and Arc ( Figure 7G ; data not shown). These results are in keeping with our original observation that CS-US pairing did not trigger nuclear translocation of hippocampal CRTC1 ( Figure 6B ). Taken together, these results provide evidence that CRTC1 functions in a region-specific manner, with a much higher contribution in the amygdala, to fine-tune the CREB output during long-term memory formation.
DISCUSSION
In this study, we combined biochemical, cell biological, pharmacological, virus-mediated genetic engineering, and behavioral approaches to decipher key neuronal regulation mechanisms of CRTC1 as a CREB coactivator, and revealed an intriguing region-specific requirement for CRTC1 during long-term fear memory formation.
The extremely Ser/Thr-rich amino acid composition of CRTC1 has so far hindered comprehensive investigation of its regulatory phosphorylation mechanisms. Here we took a highly sensitive mass spectrometric approach to determine the critical residues responsible for its activity-regulated nuclear translocation. CRTC1 is multiphosphorylated in the resting state in sharp contrast to CREB, which is dephosphorylated at a resting state, constitutively nuclear-localized, and depends on a single critical phosphorylation of Ser
133
. Among the many phosphorylation sites of CRTC1 we identified, two (Ser 151 and Ser 245 ) appeared to critically participate in the activity-dependent dephosphorylation process and contribute to the nuclear translocation of CRTC1. The kinetics of the nuclear shuttling regulated by Ser 151 and Ser 245 were in keeping with the transport rate of CRTC1 from the dendrites to the nucleus (Ch'ng et al., 2012) . Previous studies in overexpressed cells have suggested that both phosphorylation of CRTC1's C terminus and dephosphorylation of more N-terminal and central residues might regulate its nuclear transport. Here we unequivocally determined two classes of kinases, one constitutive (MARK2) and the other metabolically regulated (SIK2/AMPK), for cytoplasmic retention, and demonstrated that activity-regulated calcineurin unlocked the gating.
Furthermore, a direct transcriptional impact of nuclear CRTC1 transport on CRE/CREB-dependent gene expression was shown both in vitro and in vivo. Although a recent report suggested that in nonneuronal cells CRTC1 might augment CREB Ser 133 phosphorylation via PRMT5 (Tsai et al., 2013) , we were unable to detect such a change in CREB states in neurons (e.g., Figure 3G ). The precise mechanism by which CRTC1 may facilitate CREB's transcriptional activity while bypassing CREB phosphorylation, and how CRTC1 cooperates with other activity-regulated mechanisms, should be the focus of future study. One possible scenario we currently favor is that formation of CRTC1-CREB complex facilitates recruitment of CBP and transcription initiation complex proteins such as TAF II 130, as has been suggested in nonneuronal cells (Conkright et al., 2003; Heinrich et al., 2013) .
Finally, CREB has been widely implicated in long-term memory formation via regulation of neuronal excitability in various areas of the brain. Here we uncovered that CRTC1 modification was controlled through a complex web of both activity-regulated and unregulated pathways. Opposing CRTC1 regulation by kinases and calcineurin might permit addition of an independent tunable switch to CREB-dependent gene expression, perhaps to better regulate memory strength specifically during consolidation (Sekeres et al., 2012) . Notwithstanding this interest, evaluating the impact of endogenous CRTC1 on memory performance was previously difficult due to a severe mood dysregulation in CRTC1-null mice (Breuillaud et al., 2012) .
Recent evidence suggests that even subtle modulation of CREB signaling significantly affects an amygdala-dependent memory (Cowansage et al., 2013) . While CREB phosphorylation is mainly determined via concerted activity of several activitydependent kinases (Bito et al., 1996; Deisseroth and Tsien, 2002) , CRTC1 may be more susceptible to metabolic states of neurons and may also decode neuronal activity that is distinct from those governing CREB phosphorylation per se such as long-lasting low-frequency synaptic stimulation that strongly stimulates calcineurin (Fujii et al., 2013) . Consistent with this, we found that nuclear translocation of CRTC1 was triggered by fear conditioning only in the amygdala. Region-specific interrogation using viral vectors and CRTC1-specific reagents further unveiled that memory consolidation mechanisms downstream of CRTC1 might be differentially regulated and contribute more to fear memory formation in the amygdala than in the hippocampus.
The lack of hippocampal CRTC1 contribution in mice under our experimental conditions (Figure 7 ) does not necessarily rule out a role for hippocampal CRTC1 under circumstances where CREB-dependent gene expression may become in much higher demand. Consistent with this idea, augmented hippocampal CRTC1 expression was reported to be beneficial in rescuing behavioral and gene expression defects in 6-monthold mice that mimicked pathologies underlying Alzheimer's disease, but the same manipulation had little effect in WT mice (Parra-Damas et al., 2014) .
Taken together, our findings shed new light on the combinatorial and brain region-specific modulation of molecular cascades implicated in CRTC1-CREB-dependent gene expression crucial for formation and allocation of long-term fear memory.
EXPERIMENTAL PROCEDURES
All animal experiments were performed in accordance with the regulations and guidelines of the University of Tokyo, the Tokyo University of Agriculture, and the Japan Neuroscience Society and approved by the institutional review committee of the University of Tokyo, Graduate School of Medicine and of the Tokyo University of Agriculture.
Primary Neuron Culture and Transfection
Primary cultures of hippocampal CA neurons from postnatal days 0-1 ICR mice (SLC) were prepared as previously reported (Nonaka et al., 2006) and transfected using Lipofectamine 2000. Cortical neuron cultures from E17-18 rats were prepared, transfected using AMAXA Nucleofector electroporation system (Lonza), and seeded onto poly-D-lysine-coated dishes (Ageta-Ishihara et al., 2009 ).
Reporter Assays
Hippocampal neurons were cotransfected with a promoter-of-interest-driven luc2P plasmid, the PGK promoter-driven Renilla plasmid, and either the CRTC1 knockdown plasmid and/or mutant or WT CRTC1 expression plasmid. Neurons were treated with TTX for 5 hr and stimulated with BIC/4AP for 4 hr, then lysed. The luciferase activity of firefly normalized with Renilla was calculated (Kawashima et al., 2009 ).
Mass Spectrometry
Rat cortical neurons were transfected with FLAG-CRTC1. At 6-8 DIV, the neurons were either treated with TTX or BIC/4AP, and FLAG-CRTC1 was immunoprecipitated from the lysate, digested, and desalted. Mass spectrometry was conducted on an LTQ Orbitrap XL instrument (Thermo Fisher Scientific, San Jose). A nanoFrontier HPLC system (Hitachi) was connected to the mass spectrometer for LC-MS/MS.
ChIP Assay
Neuronal nuclear lysate preparation and ChIP were performed using a ChIP-IT Express Kit (Active Motif) as reported previously (Kawashima et al., 2009 ).
In Vivo Virus Injection
Lentivirus and AAVs were produced and purified as described in Kawashima et al. (2009) and Kawashima et al. (2013) , respectively. The viral injection procedure was essentially as described in Han et al. (2007) .
Behavioral Analysis
Fear conditioning tests were performed as previously described (Fukushima et al., 2008) . Briefly, the mice were placed in a training chamber for 148 s, and a foot shock was applied. On day 2, the mice were placed in the same chamber for 300 s (contextual test) during which the freezing was measured. Cued and contextual fear conditioning tests for experiments targeting amygdala were performed as follows; the mice were placed in a conditioning chamber ''A'' for 120 s, and a tone was applied for 30 s that coterminated with a foot shock. On day 2, the mice were placed in chamber ''B,'' and 180 s later the tone was applied for 180 s (cued test). On day 3, the mice were placed in the chamber ''A'' for 300 s (contextual test). All experiments were performed by experimenters blinded to the virus type.
Coimmunoprecipitation Assay and Western Blotting
Coimmunoprecipitation assay was performed as described previously (Okuno et al., 2012) . HEK293 cells or cortical neurons were lysed in RIPA buffer, and the lysate was mixed with primary antibody, in which protein G Sepharose (GE Healthcare, Amersham) was added later. The input and eluates were run on an acrylamide gel, blotted to PVDF membrane, and detected with an antibody.
ICC and IHC
ICC and IHC were performed in general procedures. For ICC, the cells were fixed in 4% paraformaldehyde/PBS for 15 min at RT. For IHC, mice were deeply anaesthetized and perfused with cold 2% or 4% paraformaldehyde/ PB.
All data are shown as the mean ± SEM unless otherwise indicated in the figure legend. See Supplemental Information for more detailed procedures.
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